A Leading North American Specialty Pharmaceutical Company

Medexus Pharmaceuticals, Inc. is a rapidly growing, commercial-stage specialty pharmaceutical company with an established presence across North America that is focused on an array of therapeutic areas, including rheumatology, auto-immune disease, specialty oncology and pediatrics.

About Us
Bringing Quality Healthcare Products to Market

Bringing Quality Healthcare Products to Market

For Patients and Healthcare Professionals

Our product portfolio features leading products that address a variety of diseases, including rheumatology, auto-immune disease, pediatrics, and specialty oncology

View Product Portfolio

portfolio growth

*Percentages are of the Company’s revenue as disclosed in the condensed interim consolidated statements of loss and comprehensive income (unaudited) of the Company for the nine-month period ended December 31, 2019, as filed on SEDAR, plus the pro-forma impact of Ixinity, as if the acquisition had been completed at the beginning of the fiscal year.

Our Highly Scalable Business Platform

In addition to driving organic growth through sales of products within our existing portfolio, we are actively growing our product portfolio through new product launches, new product licensing and acquisitions.

Growing Product Pipeline

Growing Product Pipeline

We continuously look to license or acquire new products and solutions aimed at addressing the essential needs of consumers, patients and health care partners, leveraging our North American sales force and infrastructure.

Licensing Targets

Canada

  • Rheumatology/Auto-immune disease
  • Hematology
  • Pediatrics
  • Allergy
  • Dermatology

USA

  • Rheumatology/Auto-immune disease
  • Hematology